KEAP1 and diabetic kidney disease: The beneficial effects of PA on DKD mechanisms are linked to various factors, such as the regulation of oxidative-antioxidant balance (LPO, PCO, SOD, and GSH), and the activation of p38 MAPK and Keap1/Nrf2 signaling pathways.